IGF-1 LR3
ResearchIGF-1 LR3 (Long Arg3-IGF-1)
- Category
- Growth Hormone
- Aliases
- Long R3 IGF-1, Long-Arg3-IGF-1
- Administration
- Subcutaneous injection
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
Localized effects at the injection site are typically the earliest noticeable pattern for regular users.
- 2
3–4 Weeks
Some users report a fuller, more "pumped" muscle appearance during use.
- 3
5–7 Weeks
Continued use is commonly associated with faster perceived recovery between training sessions.
- 4
8–10 Weeks
Muscle growth-related changes may become more noticeable when combined with training.
- 5
11–15 Weeks
Users should remain alert to symptoms of low blood sugar throughout continued use.
- 6
16–20 Weeks
This period is often described as when composition changes feel most apparent.
- 7
21–24 Weeks
Long-term users typically reassess continued use given the compound's insulin-like activity and associated risks.
⚠️ Research context only. This is not medical advice and results are not guaranteed.